Typicality: | 0.302 |
Saliency: | 0.124 |
at the recommended dose | 6 | temporal |
level → be exhibited in → postmenopausal volunteers | 6 |
negative | neutral | positive |
0.356 | 0.608 | 0.035 |
Raw frequency | 6 |
Normalized frequency | 0.124 |
Modifier score | 0.500 |
Perplexity | 395.639 |